Cellebrite DI Ltd

Cellebrite DI Ltd. engages in the provision of digital intelligence solutions for the law enforcement, government, and enterprise market. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Cellebrite reports strong Q4 performance and eyes revenue growth

Cellebrite's Q4 performance reflects strong revenue growth, robust net retention rates, and strategic investments in key areas for future growth.
While facing challenges in currency impact and competition, the company is well-positioned to capitalize on opportunities for revenue growth acceleration and market expansion.

Cellebrite reports strong Q1 performance and focuses on digital solutions

Cellebrite's Q1 call highlighted revenue growth, strategic progress, and confidence in meeting financial targets. The company's focus on digital intelligence solutions and ethical sales practices stood out, with opportunities in AI integration and market expansion.

Cellebrite reports robust Q2 earnings, eyes growth through innovation

Cellebrite's Q2 2023 earnings call showcased strong financial performance, strategic progress, and raised outlook for 2023. The company's emphasis on innovation, customer relationships, and disciplined spending positions them for continued growth and success in the digital intelligence solutions market.

Cellebrite reports record Q3 results, eyes growth in digital forensics

Cellebrite's Q3 performance showcased strong results and growth drivers, with a focus on expanding customer relationships and innovation.
The company's strategic priorities include leadership in digital forensic units, growth in investigative units, and leveraging cloud capabilities for future success.
With a robust financial outlook, Cellebrite aims to achieve revenue targets, improve EBITDA margins, and capitalize on opportunities in both public and private sectors.

Cellebrite surpasses Q4 targets, eyes market expansion and customer success

Cellebrite's strong financial performance in Q4 2023 and strategic priorities for 2024 position the company for continued growth and market leadership.
Emphasis on customer success through training initiatives and post-sale experience enhances revenue growth and customer engagement.
Opportunities in market expansion, technology investments, and customer relationships drive Cellebrite's focus on profitability and business expansion.

Cellebrite reports robust Q1 earnings, eyes growth in digital solutions

Cellebrite's Q1 2024 performance reflects strong financial metrics and strategic focus on digital solutions. While facing challenges in transitioning to new products and sustaining margins, the company is well-positioned to capitalize on growth opportunities in the public and private sectors. By leveraging its operational efficiency and market positioning, Cellebrite aims to achieve its 2024 targets and drive future growth.

Cellebrite excels in Q2 with strong growth and strategic acquisitions

Cellebrite's Q2 performance showcased robust growth driven by key products and market expansion, with a focus on enhancing customer value through AI capabilities and strategic acquisitions.
While facing challenges in execution and market dynamics, the company's emphasis on innovation and customer success presents opportunities for sustained growth and differentiation.
Overall, Cellebrite's financial updates, strategic priorities, and partnerships position it well for continued success and value creation in the digital forensic solutions market.

Cellebrite exceeds Q3 revenue targets, CEO transition announced

Cellebrite's Q3 2024 performance showcased exceptional revenue growth, profitability, and strategic initiatives to drive future success.
While facing challenges such as CEO succession and customer adoption rates, the company is well-positioned to capitalize on opportunities in cloud investments and AI capabilities.
By focusing on customer upgrades, expanding into new sectors, and optimizing its operations, Cellebrite is poised for sustained growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cellebrite DI Ltd. engages in the provision of digital investigative solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Its services include training and advisory, value realization, advanced services, and technical customer support. The firm also offers software solutions and analytic tools designed to accelerate digital investigations and address the growing complexity of handling crime and security challenges in the digital era. The company was founded on April 13, 1999 and is headquartered in Petach Tikva, Israel.

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 12, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced that it is hosting an Investor Day in New York City on Wednesday, March 27, 2024, starting at 8:30 a.m. ET. The event is designed to help investors learn more about Cellebrite's compelling value proposition, exciting growth opportunities, top strategic priorities and long-term outlook.

Cellebrite Announces 2024 Investor Day

Does Cellebrite DI Ltd. (CLBT) have what it takes to be a top stock pick for momentum investors?

Cellebrite DI Ltd. (CLBT) is a Great Momentum Stock: Should You Buy?

Collaboration with Coalfire Will Deliver Federal Customers Access to Cellebrite SaaS Technology Collaboration with Coalfire Will Deliver Federal Customers Access to Cellebrite SaaS Technology

Cellebrite Launches FedRAMP Authorization Process to Provide Federal Customers with Enhanced Cloud Security

TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced that Haim Shani has retired as a director of the Company, effective immediately. Mr. Shani had been a distinguished member of the Board since 2019, including two years as Chairman from August 2021 until August 2023.

Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth Phase

Vontier Corporation

Investors with an interest in Technology Services stocks have likely encountered both Vontier Corporation (VNT) and Cellebrite DI Ltd. (CLBT). But which of these two stocks presents investors with the better value opportunity right now?

VNT vs. CLBT: Which Stock Should Value Investors Buy Now?

Bitfarms Ltd

Mitsubishi UFJ Financial

Teekay

Zoom Video

The 5% buy zone past the breakout point in Bitfarms goes up to 3.74.

Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks? Bitcoin Miner Aims At Breakout

Cellebrite DI Ltd. (CLBT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Surging Earnings Estimates Signal Upside for Cellebrite DI Ltd. (CLBT) Stock

Cellebrite DI Ltd. (CLBT) Is Up 20.78% in One Week: What You Should Know

Cellebrite DI Ltd. (CLBT) Q4 2023 Earnings Call Transcript

Record ARR of $315.7 million, up 27% year-over-year; Record Q4 revenue of $93.0 million, up 26% year-over-year primarily due to 26% growth in subscription revenue; Record Q4 adjusted EBITDA of $22.7 million, 24.4% adjusted EBITDA margin; Full-Year 2023 performance surpasses ‘Rule of 45' with 27% ARR growth and 19% adjusted EBITDA margin TYSONS CORNER, Va. and PETAH TIKVA, Israel, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced financial results for the three and twelve months ending December 31, 2023.

Cellebrite Announces Fourth-Quarter 2023 Results

Cellebrite DI Ltd. specializes in digital forensics data extraction and management, catering to government organizations and police forces. The company has a strong moat with high customer retention and barriers to entry in the industry. I believe Cellebrite is worth $15+ versus the current stock price of $9.

Cellebrite: Growth, Profits, And Consistency

Cipher Mining

Crexendo, Inc.

Heritage Insurance Hlds

Kinross Gold

Watch to see if Teekay stock can catapult past the prior entry of 7.67, or form yet another base.

Cheap Stocks To Buy: Should You Watch These 5 Growth Stocks? Teekay Thrives In New Breakout Attempt

New Solution Suite Cements the Digital Forensic Giant's Longstanding Leadership, delivering on the global promise of Justice Accelerated New Solution Suite Cements the Digital Forensic Giant's Longstanding Leadership, delivering on the global promise of Justice Accelerated

Cellebrite Revolutionizes Investigative Workflow with Groundbreaking End-to-End Platform to Solve More Cases Faster

New Landmark Campaign Leverages the Cellebrite Platform and Promise to Accelerate Justice by Equipping and Empowering Agencies Dedicated to Protecting Youth Online New Landmark Campaign Leverages the Cellebrite Platform and Promise to Accelerate Justice by Equipping and Empowering Agencies Dedicated to Protecting Youth Online

Operation Find Them All: Cellebrite Unites Philanthropic Pioneers to Accelerate Investigations of Crimes Against Children

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the Company will participate in the upcoming 26th Annual Needham Growth Conference. Relevant details include:

Cellebrite Announces Participation in the 26th Annual Needham Growth Conference

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 10, 2024 (GLOBE NEWSWIRE) -- Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced it will report its fourth-quarter and fiscal year 2023 financial results before market open on Thursday, February 15, 2024.

Cellebrite to Report Fourth-Quarter and Fiscal Year 2023 Financial Results on February 15, 2024

Law Enforcement Agency Brings in Cellebrite Pathfinder to Accelerate Justice and enable Case Closure Law Enforcement Agency Brings in Cellebrite Pathfinder to Accelerate Justice and enable Case Closure

One of the Largest Police Departments in the U.S. Doubles Down with Cellebrite Digital Forensic Technology

BOUNTIFUL, UT / ACCESSWIRE / December 18, 2023 / OneMeta Inc. (www.onemeta.ai) (OTC Pink:ONEI). OneMeta, Inc., the most innovative and advanced provider of AI-powered translation and transcription, has appointed Thomas E.

Thomas E. Hogan to Join OneMeta, Inc. Board of Directors Brings Extensive Experience to Explosive OneMeta Growth Opportunity

American Public Education

Eton Pharmaceuticals Inc

Legalzoom.com

Playstudios

After a stellar rally in Wall Street this year, investors with limited funds but desire to participate in the market can bet on low-priced top-ranked stocks like Eton Pharmaceuticals (ETON), LegalZoom.com (LZ), PLAYSTUDIOS (MYPS), American Public Education (APEI) and Cellebrite DI (CLBT).

5 Under-$15 Stocks Wall Street Analysts Recommend Buying

Are You Looking for a Top Momentum Pick? Why Cellebrite DI Ltd.

Cellebrite demonstrates how agencies can increase productivity of digital investigations by making them smarter, more efficient and defensible Cellebrite demonstrates how agencies can increase productivity of digital investigations by making them smarter, more efficient and defensible

Cellebrite Showcases Innovations in Digital Intelligence at Milipol 2023

Brainsway

Global Industrial Co

Royal Caribbean Cruises

Carrols Restaurant Group

CLBT, BWAY, TAST, RCL and GIC are five stocks with explosive relative price strength.

5 Solid Relative Price Strength Opportunities for Investors

Earnings Estimates Moving Higher for Cellebrite DI Ltd. (CLBT): Time to Buy?

Finwise Bancorp

Progressive

FINW, PGR and CLBT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 17, 2023.

Best Momentum Stocks to Buy for November 17th

Alvarium Tiedmann Holdings Inc

Eneti Inc

This week's earnings lineup has been highlighted by quite a few small-cap stocks that have strengthening prospects after posting impressive quarterly results on Tuesday.

News for Cellebrite DI Ltd Stock (CLBT)